Elizabeth M. Davis
- Molecular Biology top 5%
- Hematology top 1%
- Oncology top 5%
- Cancer Research top 5%
- Genetics top 5%
- Co-authors
- Michelle M. Le BeauLara G. HaysHeidi OlivaresRichard S. MaserJohn H.J. PetriniJohn R. YatesJames P. CarneyMichelle Le Beau
- Topics
- Acute Myeloid Leukemia Research (20 papers)Chronic Myeloid Leukemia Treatments (8 papers)Retinoids in leukemia and cellular processes (6 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Elizabeth M. Davis
63 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Molecular Biology 2.2k
- Hematology 715
- Oncology 584
- Cancer Research 508
- Genetics 416
Countries citing papers authored by Elizabeth M. Davis
This map shows the geographic impact of Elizabeth M. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth M. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth M. Davis more than expected).
Fields of papers citing papers by Elizabeth M. Davis
This network shows the impact of papers produced by Elizabeth M. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth M. Davis. The network helps show where Elizabeth M. Davis may publish in the future.
Co-authorship network of co-authors of Elizabeth M. Davis
This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth M. Davis. A scholar is included among the top collaborators of Elizabeth M. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth M. Davis. Elizabeth M. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 22 | |
| 3 | 7 | |
| 4 | GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS | 2 |
| 5 | 12 | |
| 6 | 52 | |
| 7 | 8 | |
| 8 | 113 | |
| 9 | 29 | |
| 10 | Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors. | 53 |
| 11 | 8 | |
| 12 | 29 | |
| 13 | 29 | |
| 14 | 70 | |
| 15 | 35 | |
| 16 | 23 | |
| 17 | 1 | |
| 18 | 10 | |
| 19 | Rape Shield Statutes: Legislative Responses to Probative Dangers | 1 |
| 20 | 2 |
About Elizabeth M. Davis
Elizabeth M. Davis is a scholar working on Hematology, Genetics and Health Informatics, having authored 64 papers that have together received 3.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (20 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Retinoids in leukemia and cellular processes (6 papers). The work is most often cited by research in Hematology (715 citations), Cancer Research (508 citations) and Molecular Biology (2.2k citations). Elizabeth M. Davis has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Michelle M. Le Beau, Lara G. Hays, Heidi Olivares, Richard S. Maser, John H.J. Petrini, John R. Yates, James P. Carney, Michelle Le Beau, William F. Morgan and Rafael Espinosa. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.